Axsome Therapeutics, Inc.

AXSMNASDAQHealthcare● Active

$236.50

+$4.18(+1.80%)

Market Cap$12.2B

P/E Ratio—

52W High$239.243

52W Low$96.09

Avg Volume701K

Open$234.00

Beta0.60

Cash on Hand Financials Revenue

Axsome Therapeutics, Inc. (AXSM) Cash on Hand — Cash & Short-Term Investments

Cash & cash equivalents plus short-term investments from the balance sheet, YoY change, and net cash vs debt context.

AXSM · cash on hand · updated Dec 31, 2025

Core cash position

as of Dec 31, 2025

Cash & Short-Term Investments (CCE + ST Investments)

$322.9M▲ +2.4% vs prior year

FY · as of Dec 31, 2025 · Reported in USD

Cash & Cash Equiv. (CCE)

$322.9M

cashAndCashEquivalents

Short-Term Investments

shortTermInvestments

YoY Change vs Prior Year

+2.4%

vs prior fiscal year

Latest Quarter

$305.1M

Q1 2026

Data Scope & Methodology

Cash on Hand = Cash & Cash Equivalents (CCE) + Short-Term Investments, as reported on the balance sheet (10-K/10-Q). Also referred to as cash reserves or cash position. Not free cash flow.

Source: FMP /balance-sheet-statement · SEC 10-K / 10-Q · Reported in USD

Source: FMP /balance-sheet-statement · SEC 10-K / 10-Q · USDUpdated: December 31, 2025

Net cash vs debt

Cash vs Debt · Balance Sheet Health

Cash & ST Investments$322.9MCash on Hand

Total Debt$241.3MTotal Debt

Net Cash / Net Debt+$81.6MNet Cash Position

Cash vs Debt Ratio

Cash 57%Axsome Therapeutics, Inc. cash as % of market cap: 2.65%% · MCap $12BDebt 43%

Axsome Therapeutics, Inc. has a net cash position of $81.6M, holding more cash than debt.

Net Cash = Cash & ST Investments − Total Debt$322.9M − $241.3M = +$81.6M

Cash on hand history

annual cash on hand trend · Cash & Short-Term Investments

YoY Increase

YoY Decrease

Latest Year

AXSM annual cash on hand history · Cash & Short-Term Investments · Source: FMP /balance-sheet-statement

Annual cash on hand by year

AXSM cash & short-term investments history

DatePeriodCash & ST InvestmentsYoY Change

Dec 31, 2025LatestFY$322.9M+2.4%

Dec 31, 2024FY$315.4M-18.3%

Dec 31, 2023FY$386.2M+92.3%

Dec 31, 2022FY$200.8M+132.3%

Dec 31, 2021FY$86.5M-53.0%

AXSM cash on hand annual historical data · Cash & Short-Term Investments per balance sheet (10-K/10-Q) · Reported in USD · Source: FMP /balance-sheet-statement

Healthcare Sector Cash Reserves Comparison

AXSM vs peers · cash on hand

#CompanyCash & ST Inv.Market CapCash/MCapRelative

UnitedHealth Group Incorporated

Eli Lilly and Company

Axsome Therapeutics, Inc.YOU

AXSM

$322.9M$12B2.6%

Healthcare sector cash reserves · Source: FMP /balance-sheet-statement + /profile · Sorted by Cash desccompanies with most cash on hand →

About cash on hand & methodology

Axsome Therapeutics, Inc. (AXSM) cash on hand as of December 31, 2025 is $322.9M, comprising $322.9M in cash and cash equivalents (CCE) plus $0 in short-term investments — reported as Axsome Therapeutics, Inc. cash and short-term investments on the balance sheet (10-K filing). Also referred to as Axsome Therapeutics, Inc. cash reserves or cash position.

Axsome Therapeutics, Inc. annual cash on hand history shows increased +2.4% in 2025: increased +2.4% in 2025. Axsome Therapeutics, Inc. cash reserves in 2025 reflect the company's capital allocation strategy.

Axsome Therapeutics, Inc. carries total debt of $241.3M against cash of $322.9M, resulting in a net cash position of +$81.6M. For the full balance sheet, see the Financials → Balance Sheet tab.

Figures tie to SEC 10-K/10-Q balance sheet disclosures and FMP /balance-sheet-statement where noted.

Financial statements Free cash flow Net income Revenue Market cap P/E ratio Earnings Price history

Frequently asked questions

AXSM cash on hand · 5 questions

As of December 31, 2025, Axsome Therapeutics, Inc. (AXSM) has $322,933,000 in cash on hand — defined as cash and short-term investments on the balance sheet. This includes $322,933,000 in cash and cash equivalents (CCE) plus $0 in short-term investments. Latest quarter (March 31, 2026): $305,106,000. Data sourced from the annual 10-K filing via FMP.

AXSM cash on handAXSM cash reservesAXSM cash 2025how much cash does AXSM have

▸ Source: FMP /balance-sheet-statement · US GAAP · Axsome Therapeutics, Inc. · Axsome Therapeutics, Inc. SEC 10-K & 10-Q filings · US GAAP · Last updated: December 31, 2025